FDA expands Veklury’s use to Covid-19 patients with severe kidney disease
The move follows a positive decision made by the EMA earlier this year, broadening the use of Veklury to the high-risk patient group.
The move follows a positive decision made by the EMA earlier this year, broadening the use of Veklury to the high-risk patient group.
What's Your Reaction?
